High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years
Size: Market Cap wise it is among the top 20% companies of india.
Balance Sheet: Strong Balance Sheet.
Smart Money: Smart money has been increasing their position in the stock.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Past Returns: Underperforming stock! In past three years, the stock has provided -7.7% return compared to 9.3% by NIFTY 50.
Momentum: Stock is suffering a negative price momentum. Stock is down -10.8% in last 30 days.
Valuation | |
|---|---|
| Market Cap | 14.82 kCr |
| Price/Earnings (Trailing) | 52.6 |
| Price/Sales (Trailing) | 1.84 |
| EV/EBITDA | 16.9 |
| Price/Free Cashflow | -94.81 |
| MarketCap/EBT | 43.29 |
| Enterprise Value | 18.6 kCr |
Fundamentals | |
|---|---|
| Revenue (TTM) | 8.05 kCr |
| Rev. Growth (Yr) | 25.8% |
| Earnings (TTM) | 377.48 Cr |
| Earnings Growth (Yr) | 189% |
Profitability | |
|---|---|
| Operating Margin | 4% |
| EBT Margin | 4% |
| Return on Equity | 6.61% |
| Return on Assets | 3.23% |
| Free Cashflow Yield | -1.05% |
Growth & Returns | |
|---|---|
| Price Change 1W | -5.2% |
| Price Change 1M | -10.8% |
| Price Change 6M | 7.4% |
| Price Change 1Y | 2% |
| 3Y Cumulative Return | -7.7% |
| 5Y Cumulative Return | -9.7% |
| 7Y Cumulative Return | 0.80% |
| 10Y Cumulative Return | 12.3% |
Cash Flow & Liquidity | |
|---|---|
| Cash Flow from Investing (TTM) | -1.4 kCr |
| Cash Flow from Operations (TTM) | 1.24 kCr |
| Cash Flow from Financing (TTM) | -73.17 Cr |
| Cash & Equivalents | 144 Cr |
| Free Cash Flow (TTM) | -144.03 Cr |
| Free Cash Flow/Share (TTM) | -3.97 |
Balance Sheet | |
|---|---|
| Total Assets | 11.7 kCr |
| Total Liabilities | 5.99 kCr |
| Shareholder Equity | 5.71 kCr |
| Current Assets | 3.11 kCr |
| Current Liabilities | 3.98 kCr |
| Net PPE | 6.35 kCr |
| Inventory | 1.25 kCr |
| Goodwill | 0.00 |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.34 |
| Debt/Equity | 0.69 |
| Interest Coverage | 0.17 |
| Interest/Cashflow Ops | 5.58 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend/Share (TTM) | 1 |
| Dividend Yield | 0.24% |
| Shares Dilution (1Y) | 0.00% |
| Shares Dilution (3Y) | 0.00% |
Size: Market Cap wise it is among the top 20% companies of india.
Balance Sheet: Strong Balance Sheet.
Smart Money: Smart money has been increasing their position in the stock.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Past Returns: Underperforming stock! In past three years, the stock has provided -7.7% return compared to 9.3% by NIFTY 50.
Momentum: Stock is suffering a negative price momentum. Stock is down -10.8% in last 30 days.
Investor Care | |
|---|---|
| Dividend Yield | 0.24% |
| Dividend/Share (TTM) | 1 |
| Shares Dilution (1Y) | 0.00% |
| Earnings/Share (TTM) | 7.77 |
Financial Health | |
|---|---|
| Current Ratio | 0.78 |
| Debt/Equity | 0.69 |
Technical Indicators | |
|---|---|
| RSI (14d) | 45.04 |
| RSI (5d) | 52.41 |
| RSI (21d) | 40.61 |
| MACD Signal | Sell |
| Stochastic Oscillator Signal | Hold |
| SharesGuru Signal | Sell |
| RSI Signal | Hold |
| RSI5 Signal | Hold |
| RSI21 Signal | Hold |
| SMA 5 Signal | Sell |
| SMA 10 Signal | Sell |
| SMA 20 Signal | Sell |
| SMA 50 Signal | Sell |
| SMA 100 Signal | Sell |
Summary of Aarti Industries's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
In the Q3 FY26 earnings call of Aarti Industries, management expressed a cautiously optimistic outlook, highlighting a resilience in their operations amidst a challenging global environment marked by geopolitical tensions and trade realignments.
Key points from management include:
Revenue Performance: The company's revenue for Q3 FY26 reached Rs.2,492 crore, representing an 11% increase quarter-on-quarter, primarily driven by volume growth across major products like MMA, NT, and DCB.
EBITDA Growth: EBITDA surged to Rs.323 crore, also a rise of 11% Q-o-Q. Additionally, profit after tax climbed significantly to Rs.133 crore, up 25% Q-o-Q, attributed to improved operational performance and cost-saving initiatives.
Export Focus: Exports constituted approximately 65% of total revenues, the highest share recorded. This focus on exports has also resulted in increased working capital and a slight rise in debt and interest costs.
Future Opportunities: The India-EU Free Trade Agreement is expected to unlock long-term growth in high-end specialty chemicals. The "anti-involution" strategy from China may result in a stabilization of global pricing, benefitting quality-focused players like Aarti.
Capex Plans: The company announced an increased capex guidance for the year at Rs.1,100 crore, mainly targeting expansions in MMA capacity, DCB debottlenecking, and adding PEDA capacity. Zone 4's commissioning is expected in CY26, with a significantly lower capex anticipated for FY27 due to limited large projects.
Digital Transformation: Aarti Industries is deploying AI and digital tools across operations to enhance efficiency and reduce costs, which is seen as crucial for maintaining competitiveness.
Joint Ventures: Progress continues with JVs, particularly with Superform, expected to be operational in Q1 FY27, geared towards agrochemicals, paints, and coatings, which reflects Aarti's strategy of closer customer engagement.
Overall, Aarti Industries remains committed to leveraging market opportunities and enhancing operational efficiencies to pave the way for sustainable growth in a complex market landscape.
Here are the key questions and answers from the Q&A section of the earnings transcript:
Q1: Nitesh Dhoot: Out of the key products we sell in the U.S., the highest contribution is from MMA. Was there any tariff applying to MMA last quarter?
A1 (Suyog Kotecha): Yes, MMA had full tariff applicability in the last quarter.
Q2: Vivek Rajamani: Can you elaborate on what capacities are being targeted by the 'anti-involution' strategy in China?
A2 (Suyog Kotecha): The intent is to curb deflationary pricing and overcapacity in China. Actions include removing VAT subsidies on certain chemical products, which has led to immediate changes in global pricing, particularly impacting our NCB chain products.
Q3: Arun Prasath: Should we expect margin uptick on MMA since tariffs were previously shared?
A3 (Suyog Kotecha): Yes, it should help margins. As we renegotiate contracts, tariff reductions will improve realized prices compared to the past.
Q4: Tushar Raghatate: Your EBITDA margin is currently at 14-15%. Is this sustainable given the upcoming Zone 4?
A4 (Suyog Kotecha): For non-energy products, margins should ideally improve with the macro factors discussed, so we believe this range could be sustainable.
Q5: Nitin Agarwal: How much CAPEX is spent on Zone 4, and when do you expect optimal utilization?
A5 (Suyog Kotecha): Total CAPEX on Zone 4 will be INR 1,600-1,800 crore, mostly this year, with gradual ramp-up expected over the next two years as products undergo customer qualification.
Q6: Kumar Saumya: What is the revenue potential of the new JV and its competition?
A6 (Chetan Gandhi): Revenue potential is INR 300-400 crore, mainly focused on agrochemicals and paints, with current supplies primarily coming from China.
Q7: Aditya Khetan: When do you anticipate a recovery in agrochemical pricing?
A7 (Suyog Kotecha): Recovery is anticipated as global market changes gain traction. The overall sector has potential to reach levels seen before pressure.
These summaries encapsulate the most relevant inquiries and their responses reflecting the company's operational and strategic outlook.
Understand Aarti Industries ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| Rashesh Chandrakant Gogri | 4.09% |
| ICICI Prudential | 3.29% |
| Renil Rajendra Gogri | 3.08% |
| Mirik Rajendra Gogri | 3.08% |
| Hetal Gogri Gala | 2.75% |
| Anushakti Enterprise Private Limited | 2.75% |
| Jaya Chandrakant Gogri | 2.7% |
| Sarla Shantilal Shah | 2.6% |
| HDFC Mutual Fund | 2.47% |
| LABDHI BUSINESS TRUST (Saswat Trusteeship Private Limited) | 2.07% |
| TULIP FAMILY TRUST (Gloire Trusteeship Services Private Limited) | 1.82% |
| ORCHID FAMILY TRUST (Relacion Trusteeship Services Private Limited) | 1.82% |
| Safechem Enterprises Private Limited | 1.61% |
| Rajendra Vallabhaji Gogri | 1.57% |
| Nippon Life India Trustee Ltd | 1.56% |
| Quant Mutual Fund | 1.15% |
| Nehal Garewal | 1% |
| Heena Family Private Trust (Barclays Wealth Trustees India Private Limited) | 0.92% |
| Nikhil Parimal Desai | 0.83% |
| Bhavna Family Private Trust (Barclays Wealth Trustees India Pvt Ltd) | 0.78% |
Distribution across major stakeholders
Distribution across major institutional holders
Detailed comparison of Aarti Industries against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|---|
| SRF | SRF | 71.62 kCr | 15.6 kCr | -4.80% | -19.00% | 40.25 | 4.59 | - | - |
| PIIND | PI Industries | 42.44 kCr | 7.24 kCr | -12.80% | -20.10% | 29.24 | 5.86 | - | - |
| ATUL | Atul | 18.53 kCr | 6.22 kCr | -4.60% | +8.00% | 31.19 | 2.98 | - | - |
| VINATIORGA | Vinati Organics | 13.57 kCr | 2.31 kCr | -10.30% | -16.50% | 30.63 | 5.87 | - | - |
Comprehensive comparison against sector averages
AARTIIND metrics compared to Chemicals
| Category | AARTIIND | Chemicals |
|---|---|---|
| PE | 52.60 | 40.25 |
| PS | 1.84 | 3.73 |
| Growth | 13.2 % | 4.8 % |
Aarti Industries is a Specialty Chemicals company based in India, represented by the stock ticker AARTIIND.
With a market capitalization of Rs. 15,720.7 Crores, the company specializes in the manufacture and sale of a wide range of specialty chemicals, including:
These products are utilized in various chemical processes such as chlorination, nitration, and oxidation, among others.
Aarti Industries also produces end-use products that cater to diverse sectors, including:
Furthermore, the company provides intermediates for pharmaceuticals, agri-products, and other specialty chemical products like:
Incorporated in 1984 and headquartered in Mumbai, India, Aarti Industries has demonstrated substantial growth, with a trailing revenue of Rs. 7,110.9 Crores over the last 12 months and a revenue growth of 10.2% in the past three years.
Aarti Industries is also committed to delivering value to its investors, offering a dividend yield of 0.55% per year, with a dividend payout of Rs. 2.5 per share over the last year. Additionally, the company participates in exports, broadening its market reach.
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.
AARTIIND vs Chemicals (2021 - 2026)